Skip to main content

Advertisement

Log in

Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

The large number of women surviving many years post breast cancer (BC) diagnosis has heightened interest in studying long-term effects of cancer on quality of life (QoL). Several cancer-specific health-related measures have been developed, but these may not be appropriate for long survivors. This study evaluates the reliability and clinical and psychometric validity of the BreSAS questionnaire (BQ) among BC survivors.

Methods

The BQ is a quick, simple ten-item module for the assessment of long-term physical, psychological, sexual, and cognitive effects that may influence QoL. The total BreSAS score ranks from 0 to 100, with a low score indicating a better QoL. Patients complete the BQ, the FACT-ES questionnaire, and case report forms for clinical and socio-demographic data during follow-up visits. Reliability and clinical and psychometric validity of the questionnaires are assessed by correlation analyses and exploration of known group comparisons.

Results

From September 2015 to February 2016, 149 patients from three Italian oncology units were enrolled. Baseline questionnaires were returned from all, and 134 patients (89%) completed the BQ and FACT-ES in less than 15 min. For reliability, Cronbach’s alpha coefficients for each scale were greater than 0.70 in all analyzed symptoms. Convergent validity of BQ showed by Pearson’s r demonstrated a high correlation between intensity of symptoms and QoL, especially for pain and depression. No data were provided about reproducibility with test–retest study.

Conclusion

The BQ demonstrates sufficient validity and reliability to support its use to assess patient-reported symptoms during planned follow-up clinical visits among BC survivors. Further full validation studies are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, la Vecchia C (2017) Trends and predictions to 2020 in breast cancer mortality in Europe. Breast 36:89–95

    Article  Google Scholar 

  2. American Cancer Society (2005) Cancer facts and figures 2005. American Cancer Society, Atlanta

    Google Scholar 

  3. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivor. Accessed 10 April 2019

  4. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16(2):501–514

    Article  CAS  Google Scholar 

  5. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991 Summer) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9

    Article  CAS  Google Scholar 

  6. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55(2):189–199

    Article  CAS  Google Scholar 

  7. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G (1997 Mar) Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15(3):974–986

    Article  CAS  Google Scholar 

  8. Fayers PM, Machin D (2000) Quality of life: assessment, analysis and interpretation. John Wiley & Sons Ltd., Chichester 404 pp

    Book  Google Scholar 

  9. Tabachnik BJ, Fidel LS (1993) Using multivariate statistics. Harper & Row, London

    Google Scholar 

  10. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The EORTC QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  CAS  Google Scholar 

  11. Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 2:472–483

    Article  CAS  Google Scholar 

  12. Schag CA, Heinrich RL (1990) Development of a comprehensive quality of life measurement tool: CARES. Oncology (Williston Park) 4:135–138

    CAS  Google Scholar 

  13. Wyatt G, Friedman LL (1996) Long-term female cancer survivors: quality of life issues and clinical implications. Cancer Nurs 19:1–7

    Article  CAS  Google Scholar 

  14. Ferrell BR, Dow KH, Leigh S, Ly J, Gulasekaram P (1995) Quality of life in long-term cancer survivors. Oncol Nurs Forum 22:915–922

    CAS  PubMed  Google Scholar 

  15. Avis NE, Ip E, Foley KL (2006) Evaluation of the Quality of Life in Adult Cancer Survivors (QLACS) scale for long-term cancer survivors in a sample of breast cancer survivors. Health Qual Life Outcomes 4(1):92

    Article  Google Scholar 

  16. Brandini da Silva FC, José da Silva J, Sarri AJ, Paiva CE, Aloisio da Costa Vieira R (2019) Comprehensive validation study of quality-of-life questionnaire using objective clinical measures: breast Cancer treatment outcome scale (BCTOS), Brazilian Portuguese version. Clin Breast Cancer 19(1):e85–e100

    Article  Google Scholar 

Download references

Acknowledgments

We want to thank all the participants of the study for the additional time required to complete all the study questionnaires during the follow-up visit.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Mazzotta.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 138 kb)

ESM 2

(DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giusti, R., Scarpi, E., Cannita, K. et al. Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors. Support Care Cancer 28, 1051–1058 (2020). https://doi.org/10.1007/s00520-019-04905-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-019-04905-y

Keywords

Navigation